The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 331:737-739 September 15, 1994 Number 11
NextNext

Treating Mild Asthma -- When Are Inhaled Steroids Indicated?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Asthma affects nearly 1 in 15 people in the United States and Europe. Although the cause or causes of asthma remain unknown, its pathophysiology has been well enough characterized to allow the development of two major classes of drugs for treatment -- bronchodilators and antiinflammatory agents. In regard to the latter class, we know that corticosteroids, which have an unspecified antiinflammatory action, provide effective treatment. This appreciation has led, somewhat tautologically, to the concept that controlling airway inflammation, which is present even in patients with mild asthma,1,2,3 is an important therapeutic goal4. Indeed, guidelines for the treatment of asthma . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.